Press Releases

Date Title View
Toggle Summary Second Sight Announces Positive Reimbursement Renewal Decision in Germany
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore some functional vision to blind patients, today announced that the German Institute for the
View HTML
Toggle Summary Second Sight Medical Products, Inc. Announces Rights Offering
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq: EYES ) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced it filed a registration statement on
View HTML
Toggle Summary UK Government Announces Funding for Second Sight's Argus II "Bionic Eye"
SYLMAR, Calif. & LAUSANNE, Switzerland --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients suffering from Retinitis Pigmentosa (RP), today
View HTML
Toggle Summary Second Sight to Present at the 9th Annual LD Micro Main Event
LOS ANGELES, CA / ACCESSWIRE / November 22, 2016 / Second Sight Medical Products, Inc. ( NASDAQ : EYES) ("Second Sight" or "the Company"), a developer, manufacturer, and marketer of implantable visual prosthetics to provide a form of useful vision to blind patients, announced today that it will be
View HTML
Toggle Summary Second Sight Reports Third Quarter 2016 Financial Results
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide a form of useful vision to blind patients, today reported financial results for the three- and
View HTML
Toggle Summary Second Sight Announces Final CMS Hospital Outpatient Payment Rate for 2017 and Two New CPT Codes for Programming the Argus II Retinal Prosthesis System
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products , Inc. (NASDAQ:EYES) ("Second Sight"), a developer, manufacturer and marketer of implantable visual prosthetics that provide a form of useful vision to blind patients, today announced that the Centers for Medicare & Medicaid Services
View HTML
Toggle Summary Second Sight to Discuss Third Quarter 2016 Financial Results on November 2, 2016 Conference Call
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its third quarter 2016 financial results on Wednesday, November 2, 2016 ,
View HTML
Toggle Summary Second Sight Announces Successful Implantation and Activation of Wireless Visual Cortical Stimulator in First Human Subject
Provides Proof of Concept for the Ongoing Development of the Orion™ I Visual Cortical Prosthesis SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore
View HTML
Toggle Summary Second Sight to Present at The MicroCap Conference on October 25, 2016
SYLMAR, CA / ACCESSWIRE / October 13, 2016 / Second Sight Medical Products, Inc. ( NASDAQ : EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will present at The MicroCap Conference
View HTML
Toggle Summary Second Sight to Present at the Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products , Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will present at the Rodman & Renshaw 18th Annual Global
View HTML